{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:09:21Z","timestamp":1787062161713,"version":"build-2736575974"},"reference-count":108,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.cpcardiol.2021.100853","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T10:59:48Z","timestamp":1617706788000},"page":"100853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Triggers of Cardiovascular Diseases in Rheumatoid Arthritis"],"prefix":"10.1016","volume":"47","author":[{"given":"Mei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manman","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Wei Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2021.100853_bib0001","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.phrs.2012.11.003","article-title":"Etanercept attenuates collagen-induced arthritis by modulating the association between BAFFR expression and the production of splenic memory B cells","volume":"68","author":"Wang","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0002","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","article-title":"Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis","volume":"46","author":"Young","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0003","first-page":"1695","article-title":"Causes of death in patients with rheumatoid arthritis: comparison with siblings and matched osteoarthritis controls","volume":"34","author":"Kumar","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0004","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study","volume":"61","author":"Peters","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0005","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/ard.2008.094151","article-title":"Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation","volume":"68","author":"van Halm","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0006","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.juro.2016.02.075","article-title":"Positive surgical margins increase risk of recurrence after partial nephrectomy for high risk renal tumors","volume":"196","author":"Shah","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0007","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1568-9972(02)00100-3","article-title":"Accelerated atherogenesis in autoimmune rheumatic diseases","volume":"1","author":"Bacon","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0008","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/463620","article-title":"Cardiac manifestations of rheumatological conditions: a narrative review","author":"Owlia","year":"2012","journal-title":"ISRN Rheumatol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0009","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jacc.2016.12.033","article-title":"Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure","volume":"69","author":"Mantel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0010","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/art.30323","article-title":"A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis","volume":"63","author":"Davis","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.cpcardiol.2021.100853_bib0011","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semarthrit.2014.06.003","article-title":"Autonomic function and rheumatoid arthritis: a systematic review","volume":"44","author":"Adlan","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0012","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40257-013-0034-8","article-title":"Prevalence of metabolic syndrome in Behcet disease: a case-control study in Turkey","volume":"14","author":"Yalcin","year":"2013","journal-title":"Am J Clin Dermatol"},{"issue":"Suppl 4","key":"10.1016\/j.cpcardiol.2021.100853_bib0013","article-title":"The heart and cardiovascular manifestations in rheumatoid arthritis","volume":"45","author":"Voskuyl","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0014","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0015","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.autrev.2014.05.007","article-title":"Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation","volume":"13","author":"Lazzerini","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0016","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4330\/wjc.v9.i7.562","article-title":"Sudden cardiac death in patients with rheumatoid arthritis","volume":"9","author":"Masoud","year":"2017","journal-title":"World J Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0017","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ejim.2012.06.016","article-title":"Inflammatory arthritis as a novel risk factor for cardiovascular disease","volume":"23","author":"John","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0018","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00296-003-0357-5","article-title":"Heart rate variability in patients with rheumatoid arthritis","volume":"24","author":"Evrengul","year":"2004","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0019","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1002\/art.21349","article-title":"How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?","volume":"52","author":"Crowson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0020","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0021","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/art.23798","article-title":"The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population","volume":"58","author":"Davis","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0022","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.amjmed.2010.05.017","article-title":"Outcomes in patients with rheumatoid arthritis and myocardial infarction","volume":"123","author":"Francis","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0023","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1136\/heartjnl-2018-313313","article-title":"Interplay of inflammation, oxidative stress and cardiovascular disease in rheumatoid arthritis","volume":"104","author":"Del Buono","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0024","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/rheumatology\/kep253","article-title":"Hand deformities are important signs of disease severity in patients with early rheumatoid arthritis","volume":"48","author":"Johnsson","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0025","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3899\/jrheum.161103","article-title":"severe extraarticular manifestations in a community-based cohort of patients with rheumatoid arthritis: risk factors and incidence in relation to treatment with tumor necrosis factor Inhibitors","volume":"44","author":"Theander","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0026","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/imr.12605","article-title":"Suppression of inflammation and acquired immunity by IL-37","volume":"281","author":"Cavalli","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0027","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamacardio.2018.2695","article-title":"Myocarditis in duchenne muscular dystrophy after changing steroids","volume":"3","author":"Abutaleb","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0028","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1136\/heartjnl-2018-312979","article-title":"Cardiomyopathy, oxidative stress and impaired contractility in a rheumatoid arthritis mouse model","volume":"104","author":"Pironti","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0029","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/ar1814","article-title":"Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis","volume":"7","author":"Giles","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0030","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/ard.45.11.963","article-title":"Coronary arteritis complicating rheumatoid arthritis","volume":"45","author":"van Albada-Kuipers","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0031","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu403","article-title":"Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions","volume":"36","author":"Mason","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0032","first-page":"1839","article-title":"[Chronic inflammation and atherosclerosis]","volume":"138","author":"von Hundelshausen","year":"2013","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0033","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11154-010-9133-5","article-title":"Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community","volume":"11","author":"Siscovick","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0034","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","article-title":"Cardiovascular disease in autoimmune rheumatic diseases","volume":"12","author":"Hollan","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.acvd.2010.03.007","article-title":"High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis","volume":"103","author":"Meune","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0036","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0037","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/joim.12626","article-title":"Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis","volume":"282","author":"Koopman","year":"2017","journal-title":"J Intern Med"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0038","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autneu.2017.09.003","article-title":"Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis","volume":"208","author":"Adlan","year":"2017","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0039","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12891-016-1347-6","article-title":"Proarrhythmic risk and determinants of cardiac autonomic dysfunction in collagen-induced arthritis rats","volume":"17","author":"Lin","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0040","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3899\/jrheum.130394","article-title":"Inflammation and hypertension in rheumatoid arthritis","volume":"40","author":"Manavathongchai","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0041","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.autneu.2012.12.009","article-title":"Bidirectional neuro-glial signaling modalities in the hypothalamus: role in neurohumoral regulation","volume":"175","author":"Stern","year":"2013","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0042","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00094.2020","article-title":"Loss of dynamic regulation of G protein-coupled receptor kinase 2 by nitric oxide leads to cardiovascular dysfunction with aging","volume":"318","author":"Lieu","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0043","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1074\/jbc.M113.542589","article-title":"A long lasting beta1 adrenergic receptor stimulation of cAMP\/protein kinase A (PKA) signal in cardiac myocytes","volume":"289","author":"Fu","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0044","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fphar.2018.00563","article-title":"A Modified compound from paeoniflorin, CP-25, suppressed immune responses and synovium inflammation in collagen-induced arthritis mice","volume":"9","author":"Chen","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40744-019-00189-0","article-title":"Autoimmunity and inflammation link to cardiovascular disease risk in rheumatoid arthritis","volume":"7","author":"DeMizio","year":"2020","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0046","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2014-000009","article-title":"Therapeutic implications of autoantibodies in rheumatoid arthritis","volume":"2","author":"Aletaha","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0047","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis","volume":"64","author":"Nell","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0048","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/978-0-387-09597-4_13","article-title":"Cross-talk between tight and anchoring junctions-lesson from the testis","volume":"636","author":"Yan","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0049","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/08916930802031710","article-title":"Pro-apoptotic effects of anti-beta1-adrenergic receptor antibodies in cultured rat cardiomyocytes: actions on endoplasmic reticulum and the prosurvival PI3K-Akt pathway","volume":"41","author":"Liang","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0050","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.jacc.2006.11.051","article-title":"Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy","volume":"49","author":"Staudt","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0051","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11883-014-0435-z","article-title":"Inflammation and cardiovascular disease: from pathogenesis to therapeutic target","volume":"16","author":"Golia","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0052","doi-asserted-by":"crossref","first-page":"e6242","DOI":"10.1371\/journal.pone.0006242","article-title":"Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis","volume":"4","author":"Graf","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0053","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"issue":"Suppl 3","key":"10.1016\/j.cpcardiol.2021.100853_bib0054","article-title":"The role of interleukin-1 in the pathogenesis of rheumatoid arthritis","volume":"43","author":"Kay","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0055","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fphar.2017.00363","article-title":"IL-1beta inhibition in cardiovascular complications associated to diabetes mellitus","volume":"8","author":"Peiro","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0056","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.shk.0000226341.32786.b9","article-title":"Jak\/STAT\/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart","volume":"26","author":"Terrell","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0057","doi-asserted-by":"crossref","first-page":"H2183","DOI":"10.1152\/ajpheart.00624.2003","article-title":"Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function","volume":"287","author":"Yang","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0058","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1189\/jlb.1105674","article-title":"Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer","volume":"80","author":"Rose-John","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0059","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/147323000903700331","article-title":"Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes","volume":"37","author":"Liang","year":"2009","journal-title":"J Int Med Res"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0060","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/ard.2010.148031","article-title":"Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis","volume":"70","author":"Marder","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0061","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/rheumatology\/kei012","article-title":"Disease modification and cardiovascular risk reduction: two sides of the same coin?","volume":"44","author":"Hall","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0062","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/kep028","article-title":"Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis","volume":"48","author":"Nistala","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0063","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11033-010-0279-8","article-title":"Association between HLA-DRB1, HLA-DRQB1 alleles, and CD4(+)CD28(null) T cells in a Chinese population with coronary heart disease","volume":"38","author":"Sun","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0064","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cvr\/cvn248","article-title":"CD4+ CD28 null T cells in coronary artery disease: when helpers become killers","volume":"81","author":"Dumitriu","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijcard.2018.08.101","article-title":"Correlation between CD4(+)CD28(null) T lymphocytes, regulatory T cells and plaque rupture: an optical coherence tomography study in acute coronary syndromes","volume":"276","author":"Ruggio","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0066","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2164017","article-title":"Role of Inflammatory Cell Subtypes in Heart Failure","author":"Strassheim","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0067","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/nm.3284","article-title":"B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction","volume":"19","author":"Zouggari","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0068","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2016.11.010","article-title":"Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation","volume":"440","author":"Mancini","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0069","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000088261","article-title":"Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes","volume":"42","author":"Dominguez","year":"2005","journal-title":"J Vasc Res"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0070","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/ar3476","article-title":"Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study","volume":"13","author":"Mirjafari","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0071","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/art.38986","article-title":"Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis","volume":"67","author":"Giles","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0072","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00296-013-2714-3","article-title":"Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients","volume":"33","author":"El-Hini","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0073","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005038","article-title":"Interleukin 6 inhibition and coronary artery disease in a high-risk population: a prospective community-based clinical study","volume":"6","author":"Bacchiega","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0074","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jbspin.2018.07.002","article-title":"Serum retinol-binding protein 4 is associated with insulin resistance in patients with early and untreated rheumatoid arthritis","volume":"86","author":"Wei","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0075","first-page":"2447","article-title":"Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis","volume":"33","author":"Pamuk","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0076","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3132\/dvdr.2007.031","article-title":"Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis","volume":"4","author":"La Montagna","year":"2007","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0077","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1586\/14779072.2014.964687","article-title":"Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes","volume":"12","author":"Gargiulo","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0078","first-page":"867","article-title":"Glucocorticoids and insulin sensitivity in rheumatoid arthritis","volume":"31","author":"Dessein","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0079","first-page":"1810","article-title":"Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis\u2013a randomized study","volume":"34","author":"Hafstrom","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/1570161117666190619143842","article-title":"Cardiovascular risk in rheumatoid arthritis and mechanistic links: from pathophysiology to treatment","volume":"18","author":"Fragoulis","year":"2020","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0081","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm939","article-title":"Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases","volume":"9","author":"Feldmann","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0082","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/ard.47.9.768","article-title":"Tumour necrosis factor in synovial exudates","volume":"47","author":"Di Giovine","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0083","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10354-015-0344-y","article-title":"Anti-TNF in rheumatoid arthritis: an overview","volume":"165","author":"Radner","year":"2015","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0084","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/annrheumdis-2018-214970","article-title":"Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomized controlled TARA study","volume":"78","author":"van Mulligen","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0085","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/ard.2008.101964","article-title":"Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions","volume":"68","author":"Choy","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0086","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/annrheumdis-2011-201148","article-title":"Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis","volume":"71","author":"Daien","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0087","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/BOR.0000000000000496","article-title":"Recent advances in the treatment of rheumatoid arthritis","volume":"30","author":"Mahajan","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0088","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/annrheumdis-2013-204021","article-title":"Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFalpha inhibitors and rituximab","volume":"74","author":"Listing","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0089","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2012-202442","article-title":"Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study","volume":"73","author":"McInnes","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0090","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0091","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13075-016-1077-z","article-title":"Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis","volume":"18","author":"Meissner","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0092","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.semarthrit.2017.08.002","article-title":"Impact of anti-rheumatic treatment on cardiovascular risk in Asian patients with rheumatoid arthritis","volume":"47","author":"Cho","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0093","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2133\/dmpk.DMPK-13-RV-119","article-title":"Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy","volume":"29","author":"Inoue","year":"2014","journal-title":"Drug Metab Pharmacokinet"},{"issue":"Suppl 1","key":"10.1016\/j.cpcardiol.2021.100853_bib0094","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1538-7836.2009.03404.x","article-title":"Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)","volume":"7","author":"Ridker","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11883-017-0660-3","article-title":"Role of Inflammation in Heart Failure","volume":"19","author":"Shirazi","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0096","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.117.032790","article-title":"B Cell-activating factor neutralization aggravates atherosclerosis","volume":"138","author":"Tsiantoulas","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0097","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.4049\/jimmunol.1000033","article-title":"Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis","volume":"185","author":"Kyaw","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0098","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0099","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1586\/1744666X.2014.857602","article-title":"Understanding the role of B cells in atherosclerosis: potential clinical implications","volume":"10","author":"Morris-Rosenfeld","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0101","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15441\/ceem.16.141","article-title":"Cardiac physiologic regulation of sub-type specific adrenergic receptors in transgenic mice overexpressing beta1- and beta2-adrenergic receptors","volume":"3","author":"Kim","year":"2016","journal-title":"Clin Exp Emerg Med"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0102","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10741-016-9533-z","article-title":"The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure","volume":"21","author":"Briasoulis","year":"2016","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0103","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/CIRCULATIONAHA.112.099044","article-title":"Cytokine therapy with interleukin-2\/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis","volume":"126","author":"Dinh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0104","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopha.2016.02.001","article-title":"Advancement in contemporary diagnostic and therapeutic approaches for rheumatoid arthritis","volume":"79","author":"Kumar","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11926-016-0578-8","article-title":"rheumatoid arthritis pharmacotherapies: do they have anti-atherosclerotic activity?","volume":"18","author":"Giles","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0106","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/rheumatology\/kep456","article-title":"Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment","volume":"49","author":"Ristic","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0107","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cca.2018.08.028","article-title":"Association of serum lipids with autoantibodies and inflammatory markers in rheumatoid arthritis patients","volume":"486","author":"Gan","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cpcardiol.2021.100853_bib0108","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11926-018-0715-7","article-title":"Lipids in RA: is less not necessarily more?","volume":"20","author":"Plutzky","year":"2018","journal-title":"Curr Rheumatol Rep"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621000682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621000682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:58:10Z","timestamp":1758938290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280621000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0146280621000682"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100853","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triggers of Cardiovascular Diseases in Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100853"}}